About Bio Access Platforms
Bio Access Platforms is a Healthcare company based in Palo Alto (United States) founded in 2023 by Armen Solakhyan. AI tools for optimizing drug revenue forecasting and contract management processes. It operates on a SaaS and B2B model. Its chief executive, as recorded, is Armen Solakhyan. Bio Access Platforms offers products and services including Drug Revenue Forecaster and Drug Contract Pulse. Its focus areas include Biotech, Contract Management, Automation and Drug Revenue. Its competitors include Claritas Rx and Qualia Bio; 1 of its 2 listed competitors has raised funding.
Company details
Bio Access Platforms provides AI-powered software to enhance access to medicines worldwide. It includes Drug Revenue Forecaster for precise, scalable revenue predictions and patient flow modeling, and Drug Contract Pulse for automating contract tasks and scenario analysis. These tools help pharmaceutical companies streamline operations, reduce costs, and make data-driven decisions efficiently, though specific locations are not detailed.
- Headquarters Palo Alto, United States
- Founders Armen Solakhyan
- SectorsHealthcare
- Website bioaccessplatforms.com
- Social LinkedIn
Products & Services of Bio Access Platforms
Bio Access Platforms offers a comprehensive portfolio of products and services, including Drug Revenue Forecaster and Drug Contract Pulse.
AI software for scalable drug revenue predictions and patient flow modeling.
Platform for automating drug contract tasks and scenario analysis.
People of Bio Access Platforms
1 people are tracked at Bio Access Platforms (1 in leadership).
| Name | Role | Group |
|---|---|---|
Armen Solakhyan | Founder, CEO | Leadership |
Complete people profiles for Bio Access Platforms
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Bio Access Platforms
Bio Access Platforms has 2 listed competitors in our database, 1 of them funded. They include Claritas Rx and Qualia Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| claritasrx.com | 2011 | San Francisco, United States | $19.06M | 72 | Data integration and analytics services are offered to pharmaceutical manufacturers. | |
| qualiabio.com | 2019 | Los Angeles, United States | Offers biotech data tools, regulatory services, and economic modeling for industries. |
Detailed competitors of Bio Access Platforms
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bio Access Platforms
The website of Bio Access Platforms (bioaccessplatforms.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 47.7% vs previous month
Top companies in Medical Device Tech & Outsourcing
3 companies that operate in the same segment as Bio Access Platforms (Medical Device Tech & Outsourcing) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Home medical and respiratory equipment and supplies are distributed. | 2005 | Phoenixville, Pennsylvania, United States | USD 4 M | USD 3.24 B | 10,500 | |
Cybersecurity solutions for medical devices are provided by MedCrypt. | 2016 | San Diego, California, United States | USD 63.75 M | |||
Laboratory and production supplies and services are provided. | 1902 | Hampton, Virginia, United States | 592 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bio Access Platforms
Bio Access Platforms was founded in 2023.
Bio Access Platforms is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Armen Solakhyan is the CEO of Bio Access Platforms, as recorded in our data. They have also founded this company.
Bio Access Platforms provides AI-powered software to enhance access to medicines worldwide. It includes Drug Revenue Forecaster for precise, scalable revenue predictions and patient flow modeling, and Drug Contract Pulse for automating contract tasks and scenario analysis. These tools help pharmaceutical companies streamline operations, reduce costs, and make data-driven decisions efficiently, though specific locations are not detailed.
Bio Access Platforms's top competitors include Claritas Rx and Qualia Bio.
Bio Access Platforms offers Drug Revenue Forecaster and Drug Contract Pulse.